BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 392876)

  • 1. Intraperitoneal insulin with CAPD - an artificial pancreas.
    Flynn CT; Nanson JA
    Trans Am Soc Artif Intern Organs; 1979; 25():114-7. PubMed ID: 392876
    [No Abstract]   [Full Text] [Related]  

  • 2. Intraperitoneal insulin during peritoneal dialysis for patients with diabetes and renal failure.
    Krothapalli R; Patel HS; Lacke C; Payne W; Knight TF; Senekjian HO; Weinman EJ
    South Med J; 1983 Apr; 76(4):512-4. PubMed ID: 6340216
    [No Abstract]   [Full Text] [Related]  

  • 3. Continuous ambulatory peritoneal dialysis in diabetes mellitus. The risks and benefits of intraperitoneal insulin.
    Madden MA; Zimmerman SW; Simpson DP
    Am J Nephrol; 1982; 2(3):133-9. PubMed ID: 6758585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal dialysis in diabetics. Optimal insulin therapy on CAPD: intraperitoneal versus subcutaneous treatment.
    Scarpioni L; Ballocchi S; Scarpioni R; Cristinelli L
    Perit Dial Int; 1996; 16 Suppl 1():S275-8. PubMed ID: 8728206
    [No Abstract]   [Full Text] [Related]  

  • 5. Intraperitoneal insulin in uraemic diabetics undergoing continuous ambulatory peritoneal dialysis.
    Balducci A; Slama G; Rottembourg J; Baumelou A; Delage A
    Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1021-3. PubMed ID: 6794746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes, intraperitoneal insulin, and CAPD.
    Cohen IM; Lee S
    Clin Exp Dial Apheresis; 1981; 5(3):269-75. PubMed ID: 7037250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal insulin in the diabetic continuous ambulatory peritoneal dialysis (CAPD) patient - nursing management.
    Adair CM
    AANNT J; 1982 Apr; 9(2):62-3. PubMed ID: 7039632
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical control of diabetes by the artificial pancreas.
    Albisser AM; Leibel BS; Ewart TG; Davidovac Z; Botz CK; Zingg W; Schipper H; Gander R
    Diabetes; 1974 May; 23(5):397-404. PubMed ID: 4598090
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration.
    Quellhorst E
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S92-6. PubMed ID: 11792768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous ambulatory peritoneal dialysis (CAPD) in diabetics with end-stage renal disease.
    Amair P; Khanna R; Digenis G; Oreopoulos DG
    Int J Artif Organs; 1982 Mar; 5(2):81-2. PubMed ID: 7047411
    [No Abstract]   [Full Text] [Related]  

  • 11. Intraperitoneal administration of insulin during peritoneal dialysis of diabetic patients with terminal renal failure.
    Andersen KE; Petersen PH
    Proc Eur Dial Transplant Assoc; 1981; 18():206-11. PubMed ID: 7036148
    [No Abstract]   [Full Text] [Related]  

  • 12. [Physiopathology of diabetes and the artificial endocrine pancreas].
    Albisser AM; Leibel BS; Marliss EB; Zinman B; Botz CK; Zingg W; Murray FT; Denoga A
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():259-68. PubMed ID: 796523
    [No Abstract]   [Full Text] [Related]  

  • 13. Pancreas transplantation and the artificial pancreas: status of current experimental approaches.
    Felts PW
    South Med J; 1973 Jan; 66(1):66-73. PubMed ID: 4567170
    [No Abstract]   [Full Text] [Related]  

  • 14. [Artificial pancreatic beta cells --present status and future].
    Shigeta Y; Shichiri M
    Nihon Rinsho; 1977 Feb; 35(2):337-42. PubMed ID: 323546
    [No Abstract]   [Full Text] [Related]  

  • 15. Peritoneal dialysis in diabetic patients.
    Bertoli M; Bonfante L; Gambaro G; Cara M; Virgilio B; D'Angelo A
    Contrib Nephrol; 2001; (131):51-60. PubMed ID: 11125563
    [No Abstract]   [Full Text] [Related]  

  • 16. [Continuous ambulatory peritoneal dialysis in terminal renal-insufficiency diabetics].
    Kuhlmann H; Thomae U; Herrmann M; Eberhard K
    Med Klin; 1981 Mar; 76(6):169-76. PubMed ID: 7015094
    [No Abstract]   [Full Text] [Related]  

  • 17. [Variations in blood viscosity in the diabetic related to an artificial pancreas].
    Stoltz JF; Streiff F; Gaillard S; Voisin P; Drouin P; Rousselle D; Sery G; Deiber J
    Nouv Presse Med; 1979 May; 8(22):1852-3. PubMed ID: 382101
    [No Abstract]   [Full Text] [Related]  

  • 18. Decreased intraperitoneal insulin requirements during peritonitis on continuous ambulatory peritoneal dialysis.
    Henderson IS; Patterson KR; Leung AC
    Br Med J (Clin Res Ed); 1985 May; 290(6480):1474. PubMed ID: 3922539
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood glucose monitoring and computer regulation by means of an artificial endocrine pancreas.
    Kruse-Jarres JD; Braun G; Naegele R; Bresch M; Lehmann U
    Horm Metab Res Suppl; 1979; (8):42-5. PubMed ID: 395088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients.
    Nevalainen P; Lahtela JT; Mustonen J; Pasternack A
    Nephrol Dial Transplant; 1997 Jan; 12(1):145-50. PubMed ID: 9027790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.